drugset / Trial / NCT00666393

An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients

NCT00666393

Phase 3 Withdrawn Alza Corporation
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and clinical utility of fentanyl HCl 40 mcg system for the management of postoperative pain in pediatric inpatients.

Timeline

Start
2008-10
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 40 ug Other

Indications